Rachel Eren

1.0k total citations
21 papers, 668 citations indexed

About

Rachel Eren is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Rachel Eren has authored 21 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Immunology. Recurrent topics in Rachel Eren's work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Rachel Eren is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Rachel Eren collaborates with scholars based in Israel, United States and Sweden. Rachel Eren's co-authors include Shlomo Dagan, Amiela Globerson, Eithan Galun, Loya Abel, Dorit Zharhary, Ido Lubin, Ofer Nussbaum, Lewis F. Neville, Daniel Shouval and Ehud Ilan and has published in prestigious journals such as Hepatology, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Rachel Eren

21 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Eren Israel 13 430 380 155 98 75 21 668
J. D. Conradie South Africa 12 217 0.5× 208 0.5× 107 0.7× 121 1.2× 65 0.9× 28 559
Élodie Beaumont France 13 343 0.8× 337 0.9× 299 1.9× 90 0.9× 124 1.7× 22 776
Maria G. Canese Italy 10 787 1.8× 698 1.8× 39 0.3× 106 1.1× 171 2.3× 16 965
Michie Hashimoto Japan 12 481 1.1× 487 1.3× 45 0.3× 92 0.9× 184 2.5× 23 671
Michiaki Okada Japan 11 202 0.5× 123 0.3× 144 0.9× 76 0.8× 273 3.6× 22 618
J. Eric Hall Netherlands 6 731 1.7× 953 2.5× 72 0.5× 105 1.1× 69 0.9× 6 1.0k
M. Fóns United States 15 392 0.9× 90 0.2× 211 1.4× 154 1.6× 64 0.9× 27 649
M W Steward United Kingdom 13 176 0.4× 36 0.1× 228 1.5× 155 1.6× 50 0.7× 17 512
Takako Inoue Japan 15 558 1.3× 468 1.2× 47 0.3× 203 2.1× 111 1.5× 47 797
Romuald Patient France 11 514 1.2× 452 1.2× 71 0.5× 113 1.2× 105 1.4× 13 684

Countries citing papers authored by Rachel Eren

Since Specialization
Citations

This map shows the geographic impact of Rachel Eren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Eren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Eren more than expected).

Fields of papers citing papers by Rachel Eren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Eren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Eren. The network helps show where Rachel Eren may publish in the future.

Co-authorship network of co-authors of Rachel Eren

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Eren. A scholar is included among the top collaborators of Rachel Eren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Eren. Rachel Eren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hodak, Emmilia, Avishay Edri, Rachel Eren, et al.. (2023). mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy. Cancers. 15(17). 4421–4421. 4 indexed citations
2.
Neumann, Avidan U., S M Phillips, Samreen Ijaz, et al.. (2010). Novel Mechanism of Antibodies to Hepatitis B Virus in Blocking Viral Particle Release from Cells†. Hepatology. 52(3). 875–885. 60 indexed citations
3.
Barnea, Yoav, Yehuda Carmeli, Lewis F. Neville, et al.. (2008). Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model. Burns. 35(3). 390–396. 25 indexed citations
4.
Schiano, Thomas D., Michael Charlton, Zobair M. Younossi, et al.. (2006). Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study. Liver Transplantation. 12(9). 1381–1389. 82 indexed citations
5.
Barnea, Yoav, Yehuda Carmeli, Eyal Gur, et al.. (2006). Efficacy of Antibodies against the N-Terminal of Pseudomonas aeruginosa Flagellin for Treating Infections in a Murine Burn Wound Model. Plastic & Reconstructive Surgery. 117(7). 2284–2291. 12 indexed citations
6.
Gil, M. Luisa, Shlomo Dagan, Rachel Eren, & Daniel Gozalbo. (2006). Evaluation of the usefulness of anti-glyceraldehyde-3-phosphate dehydrogenase antibodies as a treatment for invasive candidiasis in a murine model. Antonie van Leeuwenhoek. 89(3-4). 345–350. 12 indexed citations
7.
Galun, Eithan, Norah A. Terrault, Rachel Eren, et al.. (2006). Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: Safety and antiviral activity. Journal of Hepatology. 46(1). 37–44. 30 indexed citations
8.
Neville, Lewis F., Yoav Barnea, Eyal Gur, et al.. (2005). Antibodies raised against N'-terminal Pseudomonas aeruginosa flagellin prevent mortality in lethal murine models of infection. International Journal of Molecular Medicine. 16(1). 165–71. 30 indexed citations
9.
Dagan, Shlomo & Rachel Eren. (2003). Therapeutic antibodies against viral hepatitis.. PubMed. 5(2). 148–55. 14 indexed citations
10.
Galun, Eithan, Rachel Eren, Rifaat Safadi, et al.. (2002). Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: Safety and antiviral properties. Hepatology. 35(3). 673–679. 65 indexed citations
11.
Ilan, Ehud, Rachel Eren, Ido Lubin, et al.. (2002). The Trimera mouse: a system for generating human monoclonal antibodies and modeling human diseases.. PubMed. 4(2). 102–9. 9 indexed citations
12.
Ilan, Ehud, Ofer Nussbaum, Arie Zauberman, et al.. (2002). The Hepatitis C Virus (HCV)–Trimera Mouse: A Model for Evaluation of Agents against HCV. The Journal of Infectious Diseases. 185(2). 153–161. 69 indexed citations
13.
Eren, Rachel, Ehud Ilan, Ofer Nussbaum, et al.. (2000). Preclinical Evaluation of Two Human Anti-Hepatitis B Virus (HBV) Monoclonal Antibodies in the HBV-Trimera Mouse Model and in HBV Chronic Carrier Chimpanzees. Hepatology. 32(3). 588–596. 66 indexed citations
14.
Ilan, Ehud, Shlomo Dagan, Ofer Nussbaum, et al.. (1999). The Hepatitis B Virus-Trimera Mouse: A Model for Human Hbv Infection and Evaluation of Anti–Hbv Therapeutic Agents. Hepatology. 29(2). 553–562. 81 indexed citations
15.
Fridkis‐Hareli, Masha, Rachel Eren, Ayala Sharp, et al.. (1993). MHC Recognition in Colonization of the Thymus by Bone Marrow Cells. Cellular Immunology. 149(1). 91–98. 7 indexed citations
16.
Eren, Rachel, Amiela Globerson, Loya Abel, & Dorit Zharhary. (1990). Quantitative analysis of bone marrow thymic progenitors in young and aged mice. Cellular Immunology. 127(2). 238–246. 28 indexed citations
17.
Eren, Rachel, Loya Abel, & Amiela Globerson. (1989). Syngeneic preference manifested by thymic stroma during development of thymocytes from bone marrow cells. European Journal of Immunology. 19(11). 2087–2092. 11 indexed citations
18.
Eren, Rachel, Dorit Zharhary, Loya Abel, & Amiela Globerson. (1988). Age-related changes in the capacity of bone marrow cells to differentiate in thymic organ cultures. Cellular Immunology. 112(2). 449–455. 48 indexed citations
19.
Eren, Rachel, Robert Auerbach, & Amiela Globerson. (1987). T cell ontogeny: Extrathymic and intrathymic development of embryonic lymphohemopoietic stem cells. Immunologic Research. 6(4). 279–287. 10 indexed citations
20.
Eren, Rachel & Dan Duksin. (1985). Inhibition of the formation of lipid-linked intermediates in normal and transformed cells by a purified tunicamycin homologue. Molecular and Cellular Biochemistry. 67(1). 39–46. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. D. Conradie Breakdown of academic impact, for papers by Élodie Beaumont Breakdown of academic impact, for papers by Maria G. Canese Breakdown of academic impact, for papers by Michie Hashimoto Breakdown of academic impact, for papers by Michiaki Okada Breakdown of academic impact, for papers by J. Eric Hall Breakdown of academic impact, for papers by M. Fóns Breakdown of academic impact, for papers by M W Steward Breakdown of academic impact, for papers by Takako Inoue Breakdown of academic impact, for papers by Romuald Patient
Rankless by CCL
2026